X-group (possible homology)

5018 Subunit XI (6.4 kDa protein) of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase)

Open in classification tree →

Ligands and drugs

229

Member domains

107

with ligand contacts (≤ 4 Å)

46.7% of members

with DrugDomain annotations

27.9% of members

with a DrugBank compound

27.9% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

Proteins with classified ligands

Superclasses bound (of 23)

—

Superclasses per 20 proteins

fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

Superclass	Proteins	Expected	0.25×observed / expected4×	Ratio	Significance
Lipids and lipid-like molecules	7	0.8		9.11×	not tested

enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBank	PDB ligand	Name	Domains
DB03429	CDL	Tetrastearoyl cardiolipin	64
DB01728	PEF	1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine	8
DB09114	PCF	Colfosceril palmitate	6
DB04327	PEE	Phosphatidylethanolamine	4

Most frequently bound compounds

PDB ligand	Name	Domains in contact
CDL	CARDIOLIPIN	98
PC1	1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE	38
XP4	1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHATE	36
3PE	1,2-Distearoyl-sn-glycerophosphoethanolamine	33
PLX	(9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL	15
PEF	DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE	14
PEE	1,2-dioleoyl-sn-glycero-3-phosphoethanolamine	8
PCF	1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE	5
6PE	1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE	3
PEK	(1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE	3
PX4	1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE	2
6F6	(4S,7R)-4-hydroxy-N,N,N-trimethyl-7-(octadecanoyloxy)-4,10-dioxo-3,5,9-trioxa-4lambda~5~-phosphaheptacosan-1-aminium	1
MC3	1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE	1
PSC	(7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE	1